Navigation Links
Alexza Pharmaceuticals to Present AZ-001 Phase IIb Clinical Data at,the American Headache Society Meeting

PALO ALTO, Calif., May 31, 2007 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. announced today that it will present at the 49th Annual American Headache Society Meeting the results of a Phase IIb clinical trial of Staccato(R) prochlorperazine (AZ-001) for the acute treatment of migraine headache. The poster presentation, "Efficacy and tolerability profile of AZ-001 (Staccato prochlorperazine) in patients with migraine headache" (Poster S-72), will be available for viewing at the meeting at the Hyatt Regency Chicago Hotel in Chicago, Illinois on Saturday, June 9, 2007 from 12:15 to 1:00 pm.

Alexza Pharmaceuticals is an emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. The Company has five product candidates in clinical development; AZ-001 (Staccato prochlorperazine) for the acute treatment of migraine headaches, AZ-004 (Staccato loxapine) for the treatment of acute agitation in patients with schizophrenia, AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder, AZ-003 (Staccato fentanyl) for the treatment of patients with acute pain and AZ-007 (Staccato zaleplon) for the treatment of sleep disorder in patients who have difficulty falling asleep.

CONTACT: Thomas B. King, President & CEO of Alexza Pharmaceuticals, Inc.,+1-650-687-3900, tking@alexza.com

Web site: '"/>




Page: 1 2

Related medicine technology :

1. Alexza Pharmaceuticals to Present AZ-004 (Staccato Loxapine) Clinical Data at the Annual NCDEU Meeting
2. Alexzas AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating Schizophrenic Patients With Acute Agitation
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:7/2/2015)... July 2, 2015 Legal-Bay LLC, The Lawsuit ... Joseph Goodwin in the Southern District of ... transvaginal mesh cases against Ethicon for a single trial ... cases for the 26 women include claims from the ... made my Johnson & Johnson,s Ethicon subsidiary. The cases ...
(Date:7/1/2015)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced ... the Cantor Fitzgerald Healthcare Conference in New York ... Cox , executive vice president and chief operating officer, will ... financial update on Wednesday, July 8, 2015 at 9:30 a.m. ... audio webcast of the presentation may be accessed from the ...
(Date:7/1/2015)... 2015 Research ... addition of the "2015 New Frontiers ... Business Challenges, Emerging Technologies, Competitive Landscape" ... New Frontiers in European Clinical Chemistry and ... Landscape is a new five-country strategic analysis ...
Breaking Medicine Technology:Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 22015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape 2
... USANA Health Sciences, Inc. (NYSE: ... are common in the average American diet and that dietary ...  However, USANA scientists and advising physicians caution that many important ... Dietary Guidelines for Americans, 2010 and that the ...
... 10, 2011 For the biopharmaceutical industry, the ... and difficulty - of interacting with patients to ... created both opportunities and challenges for approaching and ... To help marketing teams in the biopharmaceutical ...
Cached Medicine Technology:USDA Recognizes Benefit of Supplements in New Dietary Guidelines But Doesn't Go Far Enough 2Innovations in Patient-Focused Initiatives to Improve Outcomes 2
(Date:7/2/2015)... ... , ... ActiveBunch.com recently launched as a social network created for people with ... lifestyle community, Active Bunch allows users to connect with like-minded fitness enthusiasts from around ... or group events. , The spokesperson for Active Bunch explained the idea behind ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... with care and precision. There is an art and science that goes into ... of successfully reshaping the facial features and lives of more than 2,500 satisfied ...
(Date:7/2/2015)... ... July 02, 2015 , ... Five individuals from ... in Anniston for specialized disaster training. The team – composed of four clinicians ... California Hospital Association who attended the training, which is dedicated to preparing first ...
(Date:7/2/2015)... ... , ... After conducting a nationwide executive search led by healthcare ... Ariz., has hired Robert Trenschel, DO, as chief executive officer. A veteran physician executive ... his new duties at Yuma Regional Medical Center on July 13. , “Dr. Trenschel ...
(Date:7/2/2015)... ... 02, 2015 , ... Catalent Pharma Solutions, the leading global ... health products, today announced that it has made two key appointments at its ... Manager at Catalent’s Schorndorf facility, which provides large scale, complex oral solid manufacturing ...
Breaking Medicine News(10 mins):Health News:ActiveBunch.com Launches as a Social Community for People with Active Lifestyles 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 2Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 3Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 2Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 3Health News:Catalent Makes Two Key European Appointments in Oral Dose Manufacturing 2
... from product design and development through ... ... a,leading product design and development company, announced today that it has,received ... Services, Division of Food, Drug and Radiation Safety to,manufacture class I ...
... is the first Southern-style canned product ... by the American Heart Association, COLUMBUS, Ohio, Jan. ... lower sodium, low fat and meatless, were the first,product ... maintaining a savory,taste. Now, heart-healthy Sensibly Seasoned products also ...
... HARRISBURG, Pa., Jan. 9 Consumption of,sugary beverages can ... know that,some soft drinks contain as much as 11 ... also contain phosphoric and citric acids? Prolonged,exposure to these ... from the,tooth surface., According to Dr. Bruce Terry, ...
... Georgia Locations, ATLANTA, Jan. 9 Georgia Cancer Specialists ... -- will team,up with WSB-TV for the sixth annual "Totes ... GCS offices across Georgia on Friday, January 18,2008, from 10 ... or nearly new suitcases to foster children,in Georgia, many of ...
... say , , WEDNESDAY, Jan. 9 (HealthDay News) -- Researchers ... acid (RNA) molecules that seem to control whether or ... , These "microRNAs" essentially serve as brakes on the ... the disease to spread freely. When they are restored, ...
... WEDNESDAY, Jan. 9 (HealthDay News) -- Two new studies ... wisdom of treating with corticosteroids, intensive insulin therapy or ... , The first study compared the use of hydrocortisone ... found no improvement in survival rates. , The second ...
Cached Medicine News:Health News:Hiemstra Approved to Manufacture Medical Devices in New CER 2Health News:Glory Foods Receives Heart Healthy Certification 2Health News:Keep a Watchful Eye on Sugary Beverage Consumption 2Health News:Georgia Cancer Specialists to Sponsor Sixth Annual 'Totes 2 Tots' Suitcase Drive for Foster Children 2Health News:Georgia Cancer Specialists to Sponsor Sixth Annual 'Totes 2 Tots' Suitcase Drive for Foster Children 3Health News:Tiny RNA Molecules Control Breast Cancer's Spread 2Health News:Tiny RNA Molecules Control Breast Cancer's Spread 3Health News:Tiny RNA Molecules Control Breast Cancer's Spread 4Health News:Standard Septic Shock Treatments Ineffective 2Health News:Standard Septic Shock Treatments Ineffective 3Health News:Standard Septic Shock Treatments Ineffective 4
... Opmi Vario/NC33 system microscope provides surgeons ... pathology. These microscopes are ideal for many ... compact. Ergonomically designed at every point of ... utilized in a surgical microscope allows intuitive ...
DUALSWITCH-SHUNTSYSTEM for L-P-Derivation...
26 cm - 10 1/4, 140 mm - 5 1/2, bayonet-shaped, flexible, 90 angle, 4 mm...
Toothed pituitary rongeur....
Medicine Products: